rs3804099
rs3804099 · SaudiVarKB evidence summary derived from retained literature mentions.
7Variant mentions
7Publications
5Associated gene records
7Associated phenotype records
Associated gene records
Co-mentioned in the same publicationsAssociated phenotype records
Co-mentioned in the same publications| Phenotype | Identifier / context | Articles | Mentions |
|---|---|---|---|
| leukemia | — | 1 | 1 |
| diabetes mellitus | — | 1 | 1 |
| asthma | — | 1 | 1 |
| gastric cancer | — | 1 | 1 |
| colorectal cancer | — | 1 | 1 |
| breast cancer | — | 1 | 1 |
| lung cancer | — | 1 | 1 |
Associated population records
Co-mentioned in the same publications| Population | Identifier / context | Articles | Mentions |
|---|---|---|---|
| Saudi Arabia | — | 1 | 1 |
| Saudi Arabia | Cohort 2 | 1 | 1 |
| Saudi Arabia | Cohort 115 | 1 | 1 |
| Population record | Cohort 100 | 1 | 1 |
| Saudi Arabia | Cohort 210 | 1 | 1 |
Supporting publications
7 records- 2024Study of gene polymorphisms in Toll-like receptor 2 in patients with acute lymphoblastic leukemia.Heliyon1 mentions
- 2021Association of single-nucleotide polymorphisms in tumour necrosis factor and human leukocyte antigens genes with type 1 diabetes.International journal of immunogenetics1 mentions
- 2021Synonymous and non-synonymous polymorphisms in toll-like receptor 2 (TLR2) gene among complicated measles cases at a tertiary care hospital, Peshawar, Pakistan.Saudi medical journal1 mentions
- 2020Association of toll-like receptors 2, 4, 9 and 10 genes polymorphisms and Helicobacter pylori-related gastric diseases in Saudi patients.Indian journal of medical microbiology1 mentions
- 2018Potential role of Toll-like receptor 2 expression and polymorphisms in colon cancer susceptibility in the Saudi Arabian population.OncoTargets and therapy1 mentions
- 2017No genetic relationship between TLR2 rs4696480, rs3804100, and rs3804099 gene polymorphisms and female breast cancer in Saudi populations.OncoTargets and therapy1 mentions
- 2016Effect of smoking on the genetic makeup of toll-like receptors 2 and 6.OncoTargets and therapy1 mentions